Brief: MediciNova Receives A Notice Of Grant For A New Patent Covering Mn-166 (Ibudilast) For The Treatment Of Macular Injury In China
17/01/2024 11:05
Jan 17 (Reuters) - MediciNova Inc MNOV.O :
* MEDICINOVA RECEIVES A NOTICE OF GRANT FOR A NEW PATENT
COVERING
MN-166 (IBUDILAST) FOR THE TREATMENT OF MACULAR INJURY IN CHINA
* MEDICINOVA INC - PATENT IS EXPECTED TO EXPIRE NO EARLIER
THAN
APRIL 2040
Source text for Eikon: ID:nGNX6PN1ql
Further company coverage: MNOV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicinova
See all newsBrief: 3D Investment Partners Cuts Stake In Medicinova To 9.88% From 11.22%, Filing Shows
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX
MediciNova falls as fatty liver drug misses significance on blood-fat reduction
US STOCKS ON THE MOVE-WhiteHawk, Nvidia, Snowflake